NEW YORK (GenomeWeb) – Curetis said today that it is planning a €4.1 million ($5.0 million) equity offering and that it has secured a $10 million equity facility with a New York-based venture capital firm.

According to Curetis, it has received commitments from qualified investors in the US and Europe to purchase 854,166 newly issued shares at €4.80 each. The equity facility will allow the company to raise up to $10 million in additional equity — solely at its request — from Global Corporate Finance over a 36-month period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Sponsored by

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.